Allurion Technologies Inc (NYSE:ALUR) Share Price

Company Profile

Business description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Contact
11 Huron Drive
NatickMA01760
USA
T: +1 508 647-4000
https://www.allurion.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
137

Recommended

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.

Matthew Dolgin, CFA | 23 July 2025

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

John Abernethy | 23 July 2025

The offer price is well above our fair value.

Shaun Ler | 22 July 2025

Index	Last price	Change	% Change
All Ordinaries	9,001.40	59.90	0.67%
CAC 40	7,850.43	106.02	1.37%
DAX 40	24,240.82	198.92	0.83%
Dow JONES (US)	45,010.29	507.85	1.14%
FTSE 100	9,061.49	37.68	0.42%
HKSE	25,538.07	408.04	1.62%
NASDAQ	21,020.02	127.33	0.61%
Nikkei 225	41,171.32	1,396.40	3.51%
NZX 50 Index	12,809.98	15.92	0.12%
S&P 500	6,358.91	49.29	0.78%
S&P/ASX 200	8,737.20	60.00	0.69%
SSE Composite Index	3,582.30	0.44	0.01%